PBA
Paradigm Biocapital Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,043,280
| Closed | -$79.7M | – | 41 |
|
|
2024
Q2 | $79.7M | Sell |
2,043,280
-441,594
| -18% | -$17.2M | 3.05% | 13 |
|
|
2024
Q1 | $107M | Buy |
2,484,874
+357,474
| +17% | +$15.4M | 3.77% | 10 |
|
|
2023
Q4 | $98M | Buy |
2,127,400
+635,565
| +43% | +$29.3M | 4.59% | 10 |
|
|
2023
Q3 | $51M | Buy |
1,491,835
+502,508
| +51% | +$17.2M | 3.46% | 15 |
|
|
2023
Q2 | $38.1M | Buy |
989,327
+338,259
| +52% | +$13M | 2.94% | 15 |
|
|
2023
Q1 | $23.3M | Buy |
+651,068
| New | +$23.3M | 2.21% | 19 |
|